McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 79.87B |
| Revenue (ttm) | 287.97B |
| Net Income (ttm) | 3.00B |
| Shares Out | n/a |
| EPS (ttm) | 23.89 |
| PE Ratio | 26.62 |
| Forward PE | 20.90 |
| Dividend | 2.26 (0.26%) |
| Ex-Dividend Date | Sep 2, 2025 |
| Volume | 54 |
| Average Volume | 316 |
| Open | 868.01 |
| Previous Close | 848.94 |
| Day's Range | 848.81 - 868.01 |
| 52-Week Range | 537.75 - 859.76 |
| Beta | 0.51 |
| RSI | 72.84 |
| Earnings Date | Nov 5, 2025 |
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]
Financial Performance
In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.
Financial numbers in USD Financial StatementsNews
MCK Crosses Above Average Analyst Target
In recent trading, shares of McKesson Corp (Symbol: MCK) have crossed above the average analyst 12-month target price of $846.60, changing hands for $858.61/share. When a stock reaches the target an a...
Decoding McKesson Corp (MCK): A Strategic SWOT Insight
Decoding McKesson Corp (MCK): A Strategic SWOT Insight
UBS Raises McKesson (MCK) Price Target to $980, Maintains Buy Rating | MCK Stock News
UBS Raises McKesson (MCK) Price Target to $980, Maintains Buy Rating | MCK Stock News
McKesson (MCK) Analyst Rating Update by Baird: Price Target Raised | MCK Stock News
McKesson (MCK) Analyst Rating Update by Baird: Price Target Raised | MCK Stock News
MCK: Morgan Stanley Raises McKesson Price Target to $916, Maintains Overweight Rating | MCK ...
MCK: Morgan Stanley Raises McKesson Price Target to $916, Maintains Overweight Rating | MCK Stock News
McKesson (MCK) Q2 2026 Earnings Call Transcript
McKesson (MCK) Q2 2026 Earnings Call Transcript
MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down
McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.
McKesson Corp (MCK) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Earnings ...
McKesson Corp (MCK) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Earnings Guidance
Q2 2026 McKesson Corp Earnings Call Transcript
Q2 2026 McKesson Corp Earnings Call Transcript
McKesson Corporation 2026 Q2 - Results - Earnings Call Presentation
2025-11-05. The following slide deck was published by McKesson Corporation in conjunction with their 2026 Q2 earnings call.
McKesson raises 2026 EPS guidance to $38.35–$38.85 while advancing oncology and specialty platforms
McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript
McKesson Corporation (MCK) Q2 2026 Earnings Call November 5, 2025 4:30 PM ESTCompany ParticipantsJeni Dominguez - Head of Investor RelationsBrian Tyler -...
McKesson (MCK) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compa...
McKesson (MCK) Surpasses Q2 Earnings Estimates
McKesson (MCK) delivered earnings and revenue surprises of +10.54% and -1.45%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
McKesson raises annual profit forecast on robust demand for specialty drugs
Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.
McKesson boosts fiscal 2026 earnings forecast following Q2 EPS beat
McKesson raises fiscal 2026 EPS guidance after strong Q2 results and robust stock buybacks. Read more here.
McKesson Corp. Q2 Profit Increases, Beats Estimates
(RTTNews) - McKesson Corp. (MCK) revealed a profit for its second quarter that Increased from last year and beat the Street estimates.
McKesson Corp (MCK) Q2 Earnings: EPS of $8.92 Beats Estimates, Revenue Hits $103.2 Billion
McKesson Corp (MCK) Q2 Earnings: EPS of $8.92 Beats Estimates, Revenue Hits $103.2 Billion
McKesson Non-GAAP EPS of $9.86 beats by $0.81, revenue of $103.15B misses by $970M
McKesson Corporation Reports Fiscal 2026 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 second quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...
After-Hours Earnings Report for November 5, 2025 : APP, QCOM, ARM, HOOD, MCK, DASH, CRH, FTNT, ET, MET, ALL, FICO
The following companies are expected to report earnings after hours on 11/05/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Applovin Corporation (APP)is reporting for ...
McKesson Corp Q2 26 Earnings Conference Call At 4:30 PM ET
(RTTNews) - McKesson Corp (MCK) will host a conference call at 4:30 PM ET on November 5, 2025, to discuss Q2 26 earnings results.
Will Strong Segmental Performance Drive MCK's Top Line in Q2?
McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.
MCK Quantitative Stock Analysis
Below is Validea's guru fundamental report for MCKESSON CORP (MCK). Of the 22 guru strategies we follow, MCK rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
Noteworthy ETF Outflows: USMV, MCK, APH, MSI
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI USA Min Vol Factor ETF (Symbol: USMV) where we have detec...